28th Feb 2007 18:17
ReGen Therapeutics PLC28 February 2007 ReGen Therapeutics PLC 28 February 2007 ReGen Therapeutics Plc ("ReGen" or "the Company") TOTAL VOTING RIGHTS In conformity with the Transparency Directive's chapter 5 (DTR 5.6.1), the Boardof ReGen Therapeutics PLC (the 'Company') announces the following: As at the date of this announcement, the Company's issued share capital consistsof 846,146,110 Common Shares with a nominal value of 0.1 pence each, with votingrights ('Common Shares'). The Company does not hold any Common Shares in Treasury. Therefore the total number of Common Shares in the Company with voting rights is846,146,110. The above figure of 846,146,110 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they will determineif they are required to notify their interest in, or a change to their interestin, the share capital of the Company. - Ends - For further information please contact: Andrew MarshallGreycoat CommunicationsTel. 020 7960 6007 Rod Venables / Cecil JordaanHB CorporateTel. 020 7510 8561 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L